The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA

PURPOSE: Circulating tumor DNA (ctDNA) has good clinical guiding value for metastatic breast cancer (MBC) patients. This study aimed to apply a novel genetic analysis approach for therapeutic prediction based on ctDNA alterations. METHOD: This nonrandomized, multicenter study recruited 223 MBC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Binliang, Hu, Zheyu, Ran, Jialu, Xie, Ning, Tian, Can, Tang, Yu, Ouyang, Quchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356206/
https://www.ncbi.nlm.nih.gov/pubmed/35926241
http://dx.doi.org/10.1016/j.breast.2022.07.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356206/
https://www.ncbi.nlm.nih.gov/pubmed/35926241
http://dx.doi.org/10.1016/j.breast.2022.07.010

Ejemplares similares